Key Performance Indicators
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 0.11% |
| ROCE | 3.37% |
| Debt / Equity | 0.69% |
| RoNW | -0.57% |
| PAT Margin | 0.02% |
| EBITDA Margin | 3.73% |
| Price to Book Value | 13.69 |
IPO UPDATE ALERTS
Register for IPO Updates →Track Akums Drugs and Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.